Maxzide-25

See also: Generic Maxzide

Maxzide-25 is a brand name of hydrochlorothiazide/triamterene, approved by the FDA in the following formulation(s):

MAXZIDE-25 (hydrochlorothiazide; triamterene - tablet; oral)

• 
  Manufacturer: MYLAN BERTEK
  
  Approval date: May 13, 1988
  
  Strength(s): 25MG;37.5MG ^[AB]

Has a generic version of Maxzide-25 been approved?

Yes. The following products are equivalent to Maxzide-25:

TRIAMTERENE AND HYDROCHLOROTHIAZIDE (hydrochlorothiazide; triamterene tablet; oral)

• 
  Manufacturer: APOTEX INC
  
  Approval date: May 5, 1998
  
  Strength(s): 25MG;37.5MG ^[AB]


• 
  Manufacturer: PLIVA
  
  Approval date: April 26, 1996
  
  Strength(s): 25MG;37.5MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: April 30, 1992
  
  Strength(s): 25MG;37.5MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: September 23, 1993
  
  Strength(s): 25MG;37.5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Maxzide-25. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Maxzide-25.

See also...

• Maxzide-25 Consumer Information (Cerner Multum)
• Triamterene/Hydrochlorothiazide Consumer Information (Wolters Kluwer)
• Hydrochlorothiazide and triamterene Consumer Information (Cerner Multum)
• Triamterene and hydrochlorothiazide Advanced Consumer Information (Micromedex)